Quantification of sBCMA in Human Plasma using a High-Throughput Hybrid IP-MRM Based Mass Spectrometry Workflow

Home > Science Hub > Quantification of sBCMA in Human Plasma using a High-Throughput Hybrid IP-MRM Based Mass Spectrometry Workflow
Back to the list

July 27, 2021

Nicholas Dupuis, Luca Genovesi, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud and Lorella DiDonato

Quantification of sBCMA in Human Plasma using a High-Throughput
Hybrid IP-MRM Based Mass Spectrometry Workflow, BCMA Summit 2021

BCMASummit2021_poster

Download the poster

You might also be interested by

Infographics

Supporting Your Targeted Protein Degradation Strategies

January 31, 2023

Proteomics/Mass Spectrometry

More info

CellTalk

Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients

June 23, 2022

Proteomics/Mass Spectrometry

More info

Press Releases

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

Proteomics/Mass Spectrometry

More info

Brochures

High Performance Technologies for Cytokine Measurement

November 8, 2021

Immune Monitoring

More info